Latest Pharmaceutical manufacturing News

A woman with an umbrella passes the New York Stock Exchange, Monday, Oct. 26, 2020. U.S. stocks are drifting Tuesday, Oct. 27, 2020, as momentum slows a day after Wall Street slumped to its worst loss in a month on worries about rising virus counts and Washington’s inability to deliver more aid to the economy.  The (AP Photo/Mark Lennihan)

Stocks end another wobbly day lower as virus cases rise

Oct. 27, 2020 5:35 PM EDT

Wall Street's losses mounted for the second straight day Tuesday as momentum slows on worries about rising virus counts and Washington's inability to deliver more aid to the economy. The S&P 500 fell 0.3% after spending much of the day swinging between small gains and losses. Most of the stocks in the index...

FILE - In this Tuesday, Oct. 20, 2020 file photo, Pope Francis puts on his face mask as he attends an inter-religious ceremony for peace in the Basilica of Santa Maria in Aracoeli, in Rome Tuesday, Oct. 20, 2020. Pope Francis’ decision to forego wearing a face mask has been noticed, with some concern, by the commission of Vatican experts he appointed to help chart the Catholic Church’s path through the coronavirus pandemic and the aftermath. The Rev. Augusto Zampini, one of the key members of the pope’s COVID-19 commission, acknowledged Tuesday that at age 83 and with part of his lung removed, Francis would be at high risk for complications if he were to become infected with COVID-19. (AP Photo/Gregorio Borgia, File)

'We're working on it:' Pope's COVID advisers and the mask

Oct. 27, 2020 5:18 PM EDT

ROME (AP) — Pope Francis’ decision to forgo wearing a mask has been noticed, with some concern, by the commission of Vatican experts he appointed to help chart the Catholic Church’s path through the coronavirus pandemic and the aftermath. The Rev. Augusto Zampini, one of the key members of...

Pfizer signs are seen out front of the Pfizer Research & Development Laboratories Wednesday, July 22, 2020, in Groton, Conn.  Pfizer on Tuesday, July 28,  reported a 32% plunge in second-quarter profit, as the global coronavirus pandemic limited marketing of and new prescriptions for its medicines. Still, the biggest U.S. drugmaker posted a solid profit and nudged up parts of its 2020 financial forecast. (AP Photo/Stew Milne)

Pfizer tops 3Q earnings views, makes progress on COVID shot

Oct. 27, 2020 5:12 PM EDT

Drugmaker Pfizer, one of the leaders in the race to develop a COVID-19 vaccine, is tweaking its timeline for when it will know if its experimental two-dose vaccine works. Pfizer executives had expected data from their 44,000-person international study would show by Oct. 31 how well it prevents coronavirus...

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J.  Surging sales of cancer medicines and reduced spending helped Merck overcome a big hit from the coronavirus pandemic and increase its profit 12% in the second quarter. The  drugmaker on Friday, July 31, 2020,  increased its financial forecast for the year, all while it’s investing in development of two experimental vaccines and a possible treatment for COVID-19.  (AP Photo/Seth Wenig, File)

Strong sales of drugs, vaccines, propel Merck in 3Q

Oct. 27, 2020 3:09 PM EDT

Drugmaker Merck, bouncing back from a $1.6 billion hit from the coronavirus pandemic in the second quarter, boosted its third-quarter profit by 55% and blew past Wall Street expectations. The strong result was due to sales slightly higher than a year ago, plus restrained spending. The Kenilworth, New Jersey,...

FILE - This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients. (AP Photo/Darron Cummings, File)

Lilly stays confident in possible COVID drug after setback

Oct. 27, 2020 11:35 AM EDT

INDIANAPOLIS (AP) — Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday it remains confident that its drug may stop COVID from developing in other patients. Researchers are still studying the drug in...

Germany's Bayer to buy US gene therapy specialist AskBio

Oct. 26, 2020 4:45 AM EDT

BERLIN (AP) — German health care company Bayer said Monday it is buying Asklepios BioPharmaceutical, a U.S.-based firm specializing in gene therapy, in a deal worth up to $4 billion. Bayer said it will pay $2 billion up front for privately held AskBio plus “potential success-based milestone...

A worker moves boxes at Snowman Logistics, India's largest cold storage company in Taloja, on the outskirts of Mumbai, India, Saturday, Oct. 17, 2020. The vaccine cold chain hurdle is just the latest disparity of the pandemic weighted against the poor, who more often live and work in crowded conditions that allow the virus to spread, have little access to medical oxygen vital to COVID-19 treatment, and whose health systems lack labs, supplies or technicians to carry out large-scale testing. (AP Photo/Rajanish Kakade)

Vaccine storage issues could leave 3B people without access

Oct. 25, 2020 3:02 PM EDT

GAMPELA, Burkina Faso (AP) — The chain breaks here, in a tiny medical clinic in Burkina Faso that went nearly a year without a working refrigerator. From factory to syringe, the world’s most promising coronavirus vaccine candidates need non-stop sterile refrigeration to stay potent and safe. But...

A policeman checks documents of a driver at central Syntagma square in Athens, Greece, Sunday, Oct. 25, 2020. Greece's government has imposed a nightly curfew in greater Athens and other areas with high infection rates as well as a mask requirement. (AP Photo/Yorgos Karahalis)

The Latest: New outbreak delays easing of rules in Melbourne

Oct. 24, 2020 11:40 PM EDT

MELBOURNE, Australia — A COVID-19 outbreak in the north of Melbourne has led health authorities in Australia’s Victoria state to hold off on any further easing of restrictions in the beleaguered city. Victoria Premier Daniel Andrews withheld any announcement on an easing on Sunday as the state...

A woman, right, has a meal, inside a restaurant's outdoor tent Thursday Oct. 22, 2020, in Kew Gardens in the Queens borough of New York.  Gov. Andrew Cuomo is easing restrictions slightly in some coronavirus hot spots in New York City, but adding them in areas along the Pennsylvania border as the state recorded more than 2,000 new infections in a single day for the first time since mid-May. (AP Photo/Bebeto Matthews)

The Latest: Mexico's Chihuahua border state back in lockdown

Oct. 23, 2020 9:26 PM EDT

MEXICO CITY — Mexico’s northern border state of Chihuahua returned to the highest level of alert and lockdown Friday after coronavirus cases jumped there and hospitals began to fill up. The Chihuahua state government declared the return to the “red” level of alert Friday, which closes...

FILE - In this Wednesday, June 24, 2020 file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. On Friday, Oct. 23, 2020, AstraZeneca Inc. announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S. (Siphiwe Sibeko/Pool via AP)

AstraZeneca, J&J resuming US tests of COVID-19 vaccines

Oct. 23, 2020 6:31 PM EDT

Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates. Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study...